top of page
MEMORANDUMS OF UNDERSTANDING
DOMESTIC
The purpose of this Partnership Agreement is to coordinate and expand food protection efforts between the FDA and the New York State Department of Agriculture and Markets.
New York State Department of Agriculture and Markets
Office of Regulatory Affairs/ Office of Partnership and Operational Policy Office of Regulatory Affairs/ Office of Human and Animal Food Operations/ Human and Animal Food East – Division 1 Office of Regulatory Affairs/ Office of Import Operations/ Division of Northeast Imports Office of Regulatory Affairs/ Office of Regulatory Science / Office of Human and Animal Foods Laboratory Operations/ New York Human and Animal Food Laboratory
2023-02-15
2026-02-14
Coordination and collaborative efforts towards widespread use of MPS in advancing novel therapies that are safe and effective, and in biomedical research.
National Institutes of Health (NCATS)
Khaled Bouri, Ph.D; MPH ORSI/OCS/OC/FDA 10903 New Hampshire Ave, Silver Spring, MD 20993 Phone: (301) 796-8476 Email: khaled.bouri@fda.hhs.gov
2023-01-12
Indefinite
To foster cooperation, communication, and common practices in human health assessments and to harmonize hazard assessment methodologies.
Center for Public Health and Environmental Assessment (CPHEA) of the U.S. Environmental Protection Agency (EPA)
CFSAN Office of the Center Director (OCD) Suzanne Fitzpatrick Senior Advisor for Toxicology Suzanne.Fitzpatrick@fda.hhs.gov
2023-01-09
2028-01-09
The purpose of this Partnership Agreement is to coordinate, streamline processes, and enhance food protection efforts between the FDA and Virginia Department of Agriculture and Consumer Services.
Virginia Department of Agriculture and Consumer Services
Office of Regulatory Affairs Office of Partnership and Operational Policy Office of Regulatory Affairs Office of Human and Animal Food Operations/Human and Animal Food East - Division 2
2022-09-30
2025-08-31
Provides a framework for collaboration intended to facilitate regulatory and basic science innovation surrounding the medical device development pathway with respect to emerging technologies.
VA Ventures (VA Ventures) of the U.S. Department of Veterans Affairs (VA)
Ed Margerrison, PhD Organizational Sponsor Edward.Margerrison@fda.hhs.gov 240-402-0241 Zane Arp, PhD Project Manager zane.arp@fda.hhs.gov 240-402-0241 Dorn Carranza, PhD MBA Program Manager Dorn.Carranza@fda.hhs.gov 301-796-8338
2022-09-22
2027-09-22
CDC MOU to advance safe food practices
Centers for Disease Control and Prevention’s (CDC) National Center for Environmental Health (NCEH)
Abe Brown Office of Partnerships Abe.brown@fda.hhs.gov
2022-09-21
2023-09-21
To improve and sustain federal coordination and collaboration on issues related to pharmaceuticals in drinking water.
Environmental Protection Agency (EPA/OW) Department of Agriculture (USDA/ARS) Department of Interior (DOI/USGS)
CDER Dr. Douglas C. Throckmorton 301-796-5400
2022-08-30
2027-08-30
Partnership Agreement Between the U.S. Food and Drug Administration and the Iowa Department of Inspections & Appeals, Food and Consumer Safety
Iowa Department of Inspections & Appeals, Food and Consumer Safety
LaTonya Mitchell Program Division Director FDA Office of Regulatory Affairs Office of Human and Animal Food Operations West 2
2022-07-18
2025-07-18
Establish a framework for the sharing of information between the Alcohol and Tobacco Tax and Trade Bureau (TTB) and the FDA Center for Tobacco Products (CTP) relating to tobacco products regulated by the respective agencies.
Alcohol and Tobacco Tax and Trade Bureau (TTB)
CTP Office of ManagementTobaccoUserFees@fda.hhs.gov
2022-06-21
Indefinite
To enhance testing surge capacity outside of CDC and public health laboratories before and during public health emergencies
AdvaMed, ACLA, AMP, APHL, CAP, CSTE, NILA, COLA Inc., ASPR, and the CDC/OLSS/DLS
Jennifer Ross Regulatory Counsel Jennifer.ross@fda.hhs.gov
2022-05-06
Indefinite
Hawaii MOU for Consumer Protection
Hawaii Dept of Agriculture Hawaii Dept of Health University of Hawaii
Dan Solis Office of Enforcement & Import Operationsdan.solis@fda.hhs.gov
2022-03-10
2025-03-10
Provides a framework for NIH NCATS and FDA CDER discussion with scientific, medical and regulatory communities about rare disease drug and biological product development.
NIH National Center for Advancing Translational Sciences (NCATS)
Kerry Jo Lee, MD Associate Director for Rare Diseases, DRDMG, ORPURM, OND, CDER
2022-03-07
Indefinite
bottom of page